Bethesda Healthcare Ltd 07830186 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is that of an investment holding company. Digita Accounts Production Advanced 6.30.9574.0 true false 07830186 2024-01-01 2024-12-31 07830186 2024-12-31 07830186 core:CurrentFinancialInstruments 2024-12-31 07830186 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07830186 bus:SmallEntities 2024-01-01 2024-12-31 07830186 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 07830186 bus:FilletedAccounts 2024-01-01 2024-12-31 07830186 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07830186 bus:RegisteredOffice 2024-01-01 2024-12-31 07830186 bus:Director4 2024-01-01 2024-12-31 07830186 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07830186 countries:EnglandWales 2024-01-01 2024-12-31 07830186 core:CostValuation 2023-12-31 07830186 2023-01-01 2023-12-31 07830186 2023-12-31 07830186 core:CurrentFinancialInstruments 2023-12-31 07830186 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 iso4217:GBP xbrli:pure

Bethesda Healthcare Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Bethesda Healthcare Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 5

 

Bethesda Healthcare Ltd

Company Information

Director:

C Hyman

Registered office:

Savoy House
Savoy Circus
London
W3 7DA

Registered number:

07830186

Accountants:

Wem & Co
Chartered Accountants
Savoy House
Savoy Circus
London
W3 7DA

 

Bethesda Healthcare Ltd

(Registration number: 07830186)
Balance Sheet as at 31 December 2024

Note

31.12.24

31.12.23

   

£

£

£

£

FIXED ASSETS

   

 

Investments

4

 

101

 

101

CURRENT ASSETS

   

 

Debtors

5

43,255

 

42,255

 

Cash at bank and in hand

 

5,581

 

5,308

 

 

48,836

 

47,563

 

CREDITORS

   

 

Creditors within 1yr

6

22,356

 

21,219

 

Net current assets

   

26,480

 

26,344

Net assets

   

26,581

 

26,445

CAPITAL AND RESERVES

   

 

Called up share capital

 

2

 

2

Profit and loss account

 

26,579

 

26,443

Shareholders' funds

   

26,581

 

26,445

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 30 September 2025

.........................................
C Hyman
Director

 

Bethesda Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1.

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Savoy House
Savoy Circus
London
W3 7DA
England

These financial statements were authorised for issue by the director on 30 September 2025.

2.

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentational currency is Pound Sterling (£).

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.


Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.


The Group inludes a number of companies, which are a part of a tax group for certain aspects of the tax legislation. One of these aspects relates to group relief whereby current tax liabilities can be offset by current tax losses arising in other companies within the same tax group. Payment for group relief is made equal to the tax benefit and amounts are included within the current tax disclosures.

 

Bethesda Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024 (continued)

2

Accounting policies (continued)

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Dividends

3.

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2023 - 0).

4.

Fixed Asset Investments

Share in group undertakings
£

Cost or valuation

At 1 January 2024

101

Provision

Carrying amount

At 31 December 2024

101

At 31 December 2023

101

5.

Debtors

Note

31.12.24
£

31.12.23
£

Amounts owed by group undertakings

42,255

41,255

Other debtors

 

1,000

1,000

 

43,255

42,255

Amount owned by group undertakings have no set interest or repayment terms.

 

Bethesda Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024 (continued)

6.

Creditors

Creditors: amounts falling due within one year

Note

31.12.24
£

31.12.23
£

Due within one year

 

Trade creditors

 

127

127

Amounts owed by group undertakings

20,240

20,122

Accruals and deferred income

 

1,989

970

 

22,356

21,219

Amount owed to group undertakings have no set interest or repayment terms.

 

7.

Related Party Disclosures

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’, not to disclose related party transactions with wholly owned subsidiaries within the group.